Your session is about to expire
← Back to Search
Robotic Training for Limited Mobility(RoWaCaWa Trial)
RoWaCaWa Trial Summary
This trial is designed to help children with nervous system disorders who have difficulty walking on their own. A robotic trainer is a device that helps with movement and rehabilitation. The study will assess the feasibility and impacts of delivering robotic gait training at home.
- Limited Mobility
- Spina Bifida
- Spinal Cord Injury
- Cerebral Palsy
- Traumatic Brain Injury
RoWaCaWa Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
RoWaCaWa Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
RoWaCaWa Trial Design
Find a Location
Who is running the clinical trial?
- You must be at least 4 years old.You are able to fulfill training requirements throughout training period (5 days/week for at least 30 minutes each session).You are able to comply with study procedures (assessments, training).You experience pain or dizziness when standing up.You have tight muscles that prevent you from moving forward with the Trexo robotic gait trainer.You are the right size and weight to use the Trexo robotic gait trainer.You cannot walk by yourself because of a brain disorder or injury that happened when you were a child.You have a medical condition or have had recent surgery that requires you to keep your legs still or limits how much weight you can put on them.You are currently in another treatment that might affect the study results.You can physically fit into the Trexo robotic gait trainer based on your leg length and weight.You cannot walk on your own because of a childhood brain or nervous system condition.
- Group 1: Robotic Training Period
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies in this trial to which participants may apply?
"Affirmative. According to information on clinicaltrials.gov, the trial is currently seeking volunteers and was first published on July 4th 2022 with recent revisions made on August 8th 2022. The study requires 12 individuals at a single site of recruitment."
What are the primary aims of this medical experiment?
"The primary measure of success for this trial is Training Frequency. Secondary outcomes being monitored include Bowel Function, Number of Participants Enrolled and Completed, as well as Voluntary Muscle Activity. All these metrics will be assessed at various stages such enrollment (Week 0), before Robotic Gait Training period (~Week 4), following Robotic Gait Training period (~Week 16), and at 3-months post-training (~Week 28)."
What is the approximate sample size for this clinical trial?
"Affirmative. Records on the clinicaltrials website signify that this investigation, which originated on July 4th 2022, is actively seeking participants. Thus far 12 patients have been recruited from a single location."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends